-
-
Your guess is as good as ours :-)
I wonder if this is an "illumina" clone meant only for the asian markets (like some phones out there). Illustration looks suspiciously like a GAIIx. -
Copying 10 year old technology doesn't seem very new to me.Comment
-
Comment
-
From the 'Investors' page:
"We will start by fulfilling the research needs in Asia…"
Is it really racist to note that some products are available only in certain markets?Last edited by HESmith; 02-29-2016, 12:39 PM.Comment
-
-
In the light of the following information, yes I would say so, someone should inform Illumina, if they are not already aware.:-Originally posted by HESmith View Post
Domain Name: genedrabio.com
Registry Domain ID: 1942725406_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2015-06-28T02:29:22Z
Creation Date: 2015-06-28T00:00:00Z
Registrar Registration Expiration Date: 2016-06-28T02:28:51Z
Registrar: Ascio Technologies, Inc
Registrar IANA ID: 106
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +44.2070159370
Domain Status: OK
Registry Registrant ID:
Registrant Name: Tseegii Baasanjav
Registrant Organization: Gendra Biotech, Inc.
Registrant Street: 4730 Milano Way
Registrant Street: CA
Registrant City: Oceanside
Registrant State/Province:
Registrant Postal Code: 92087
Registrant Country: US
Registrant Phone: +1.8585252770
Registrant Phone Ext:
Registrant Fax:
Registrant Fax Ext:
Registrant Email: [email protected]
Registry Admin ID:
Admin Name: Host Master
Admin Organization: One.com
Admin Street: Kalvebod Brygge 24
Admin City: Copenhagen V
Admin State/Province: Copenhagen V
Admin Postal Code: 1560
Admin Country: DK
Admin Phone: +45.46907100
Admin Phone Ext:
Admin Fax: +45.70205872
Admin Fax Ext:
Admin Email: [email protected]
Registry Tech ID:
Tech Name: Host Master
Tech Organization: One.com
Tech Street: Kalvebod Brygge 24
Tech City: Copenhagen V
Tech State/Province: Copenhagen V
Tech Postal Code: 1560
Tech Country: DK
Tech Phone: +45.46907100
Tech Phone Ext:
Tech Fax: +45.70205872
Tech Fax Ext:
Tech Email: [email protected]
Name Server: ns01.one.com
Name Server: ns02.one.com
DNSSEC: unsigned
URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
>>> Last update of WHOIS database: 2016-03-02T16:55:16 UTC <<<Comment
-
The initial patent around the MinION technology is about 20 years old....Originally posted by NextGenSeq View PostComment
-
Do you have a ref for that? I would find it useful and interesting, as I am sure, many others will.Originally posted by gringer View PostComment
-
But this company is using SBS chemistry which is basically a modification of Sanger sequencing which is about 40 years old.Originally posted by gringer View PostComment
-
-
-
If genedrabio has actually managed to reverse-engineer SBS chemistry (even for GAII) then that may be a feat in itself.
There is more information about SBS here: http://www.genedrabio.com/en/seq_reagents.php
Are Illumina's original patents on this expiring?Last edited by GenoMax; 03-02-2016, 12:21 PM.Comment
-
A company is registered on this same address by J. O. AdamsOriginally posted by dannyhi321 View Post
Appears to be the same person associated with Azco, polonator and Max-Seq
Comment
-
Additional info on mr J. O. Adams
"Beijing Dragon Tech Biotechnology Limited (GenendraBiotech) to focus on second-generation sequencing (NGS), and for the field of science, protein molecular genomics, molecular biology, the genome, providing testing equipment, SBS Reagent Pack, entrapping packet sequence, molecular chemistry test package, PCR and real-time PCR instruments, gel electrophoresis systems, core technology competitive products. Companies academic leaders and CEOJMr. ADAMS scientists have several degrees and many years of relevant experience in molecular biology, biochemistry, genomics, etc., worked in related fields published several academic papers, and won the Nobel Prize, founded in the United States also successfully live their genomic tools company."
Has he really won the nobel prize?Last edited by scott_williams; 03-07-2016, 08:38 AM.Comment
Tweet
-
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...Yesterday, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM -
Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.07-01-2026, 11:43 AM
Comment